●●○ medium
There is no confirmed −; independently verified + decide the position (B). No unreachable strike-through.= non-additive meter
Kasha Global, Inc.: Women's health, delivered discreetly to the last mile. In Rwanda, many women can't get essentials like contraceptives and pregnancy tests — they aren't sold where they live, or stigma and shame around sexuality make buying in public a major hurdle. In 2016, Joanna Bichsel and Amanda Arch, who had both worked at Microsoft, moved to Rwanda out of a shared frustration that “the life-saving technology I saw in Seattle isn't reaching developing countries,” and launched the for-profit social enterprise Kasha. Kasha lets women order — via a smartphone app or by phone call from a basic feature phone — contraceptives, menstrual products, HIV self-tests, maternal/newborn health items, and non-communicable-disease drugs, discreetly, delivered to the door. Delivery is by over 200 trained agents (many low-income women), connecting urban and rural areas in Rwanda, Kenya, and South Africa. About 65% of customers are low-income women. It has obtained a wholesale license for pharmacies and, with Rwanda's Ministry of Health, has sold over 8,000 HIV self-test kits. It raised $21 million in a Series B. The letter is B; certainty is medium. Unconfirmed concerns are placed under “Watching.” (As of 2026-Q2; estimate based on public information.)
Main narrative
In Rwanda, many women can't get essentials like contraceptives and pregnancy tests — they aren't sold where they live, or stigma and shame around sexuality make buying in public a major hurdle. In 2016, Joanna Bichsel and Amanda Arch, who had both worked at Microsoft, moved to Rwanda out of a shared frustration that “the life-saving technology I saw in Seattle isn't reaching developing countries,” and launched the for-profit social enterprise Kasha.
Kasha lets women order — via a smartphone app or by phone call from a basic feature phone — contraceptives, menstrual products, HIV self-tests, maternal/newborn health items, and non-communicable-disease drugs, discreetly, delivered to the door. Delivery is by over 200 trained agents (many low-income women), connecting urban and rural areas in Rwanda, Kenya, and South Africa. About 65% of customers are low-income women. It has obtained a wholesale license for pharmacies and, with Rwanda's Ministry of Health, has sold over 8,000 HIV self-test kits. It raised $21 million in a Series B.
One person’s story (N1)
+ before → after
For a woman in rural Rwanda, contraceptives and HIV tests lay behind a double wall — the physical wall of nothing sold nearby, and the wall of stigma if seen buying in public. With Kasha she can order with a single phone call even from a borrowed basic phone, and a trained local woman agent delivers it to her door in an unmarked package. To decide about her own body, unknown to anyone — that dignity reaches the woman at the end of the last mile.
Source nature: Swedfund / Fast Company / P3 development finance institution/major media. Positive effects are not used to offset negatives.
Positive / negative effects
+ effects
- Kasha partnered with Rwanda's Ministry of Health to sell over 8,000 HIV self-test kits. Development finance institutions and public investors such as Finnfund, Swedfund, the U.S. DFC, and Mastercard invested (the Series B was $21 million, led by Knife Capital), and about 65% of customers are low-income women facing access barriers in both quality and price. Sweden's Swedfund frames the investment in terms of SRHR (sexual and reproductive health and rights) — the right to decide about one's own body.P3 development finance institution / Swedfund / DFC / Finnfund / Rwanda Ministry of Health
− effects (confirmed)
- No confirmed −.
- Independent verification of reach/health outcomes; rural last-mile and supply-chain sustainability; per-country regulation; balancing scale with quality
A second look
Scale and outcomes (women reached, health improvement) are mainly company-reported, with no confirmed independent third-party quantitative outcome evaluation or major awards. It is a for-profit, VC/DFI-backed startup, with challenges in rural last-mile and supply-chain sustainability and regulation. Its value core is providing “discreet, reliable access,” not yet demonstrated population-level health improvement.
Sources
How to read this assessment
- Reachable upper bound (ceiling): a confirmed − sets the ceiling, and independently verified + decide the position within it. + do not cancel out −.
- The weight of evidence is not symmetric: only confirmed − are counted; the volume of disputes or allegations goes under “Watching.” + are counted from independent evidence, while an organization’s own PR is treated as “reference.”
- Size is not value: scale is not used in the assessment. Matters that stay within money or competition—investors, shareholders, sanctions, trade secrets—are also excluded.
- The letter (assessment) and certainty (how reliable the information is) are separate axes.
This is a translation; the Japanese version is authoritative. The assessments here are generated automatically by AI based on published criteria. The operator does not alter individual results. Because they are AI-generated they may contain errors, and they are opinion and commentary, not statements of fact. Where evidence is insufficient, the entry is marked “On hold.” Requests for correction are accepted via the form.
Terms: Narrative Value = an assessment (A–G) of the distance between the story an organization tells and its reality / Ceiling meter = a visualization of the reachable upper bound / Watching = unconfirmed matters not counted / Protected stakeholders = people, animals, nature, and future generations. | Generated by: AI | As of: 2026-Q2 | Back to top